Huntington's disease, The Lancet, vol.369, issue.9557, pp.218-228, 2007. ,
DOI : 10.1016/S0140-6736(07)60111-1
Huntington's disease: a clinical review, Orphanet Journal of Rare Diseases, vol.5, issue.1, p.40, 2010. ,
DOI : 10.1186/1750-1172-5-40
Physiopathologie de la maladie de Huntington??: ??tat des connaissances, Revue Neurologique, vol.164, issue.12, pp.977-994, 2008. ,
DOI : 10.1016/j.neurol.2008.03.006
A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington???s disease, Orphanet Journal of Rare Diseases, vol.74, issue.1, p.114, 2014. ,
DOI : 10.1186/s13023-014-0114-8
Detection of Huntington's disease decades before diagnosis: the Predict-HD study, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.8, pp.874-880, 2008. ,
DOI : 10.1136/jnnp.2007.128728
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data, The Lancet Neurology, vol.8, issue.9, pp.791-801, 2009. ,
DOI : 10.1016/S1474-4422(09)70170-X
Onset and rate of striatal atrophy in preclinical Huntington disease, Neurology, vol.63, issue.1, pp.66-72, 2004. ,
DOI : 10.1212/01.WNL.0000132965.14653.D1
Mild cognitive impairment in prediagnosed Huntington disease, Neurology, vol.75, issue.6, pp.500-507, 2010. ,
DOI : 10.1212/WNL.0b013e3181eccfa2
Diagnostic criteria for Huntington's disease based on natural history, Movement Disorders, vol.29, issue.11, pp.1335-1341, 2014. ,
DOI : 10.1002/mds.26011
Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington???s disease, Vision Research, vol.44, issue.23, pp.2729-2736, 2004. ,
DOI : 10.1016/j.visres.2004.06.006
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.12, p.1184, 2010. ,
DOI : 10.1136/jnnp.2010.209668
Progression of Symptoms in the Early and Middle Stages of Huntington Disease, Archives of Neurology, vol.58, issue.2, pp.273-278, 2001. ,
DOI : 10.1001/archneur.58.2.273
Cognitive and functional decline in Huntington's disease: Dementia criteria revisited, Movement Disorders, vol.71, issue.9, pp.1163-1169, 2010. ,
DOI : 10.1002/mds.22953
Cognitive Impairment in Huntington Disease: Diagnosis and Treatment, Current Neurology and Neuroscience Reports, vol.75, issue.1, pp.474-483, 2011. ,
DOI : 10.1007/s11910-011-0215-x
Episodic memory impairment in Huntington's disease: A meta-analysis, Neuropsychologia, vol.44, issue.10, pp.1984-1994, 2006. ,
DOI : 10.1016/j.neuropsychologia.2006.01.015
The many facets of unawareness in huntington disease, Tremor Hyperkinetic Mov. N. Y. N, vol.4, p.257, 2014. ,
Psychopathology in Verified Huntington???s Disease Gene Carriers, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.19, issue.4, pp.441-448, 2007. ,
DOI : 10.1176/jnp.2007.19.4.441
Suicidal ideation in a European Huntington's disease population, Journal of Affective Disorders, vol.151, issue.1 ,
DOI : 10.1016/j.jad.2013.06.001
Anxiety in Huntington???s Disease, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.27, issue.4 ,
DOI : 10.1176/appi.neuropsych.14100265
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY), Journal of Neurology, Neurosurgery & Psychiatry, vol.64, issue.12, pp.1411-1418, 2014. ,
DOI : 10.1136/jnnp-2013-307343
Weight loss in Huntington disease increases with higher CAG repeat number, Neurology, vol.71, issue.19, pp.1506-1513, 2008. ,
DOI : 10.1212/01.wnl.0000334276.09729.0e
Weight loss in early stage of Huntington's disease, Neurology, vol.59, issue.9, pp.1325-1330, 2002. ,
DOI : 10.1212/01.WNL.0000031791.10922.CF
Factors Associated With Slow Progression in Huntington's Disease, Archives of Neurology, vol.48, issue.8, pp.800-804, 1991. ,
DOI : 10.1001/archneur.1991.00530200036015
Neuroendocrine Disturbances in Huntington's Disease, PLoS ONE, vol.156, issue.3, p.4962, 2009. ,
DOI : 10.1371/journal.pone.0004962.t004
Psychiatric and Cognitive Difficulties as Indicators of Juvenile Huntington Disease Onset in 29 Patients, Archives of Neurology, vol.64, issue.6, pp.813-819, 2007. ,
DOI : 10.1001/archneur.64.6.813
Managing juvenile Huntington???s disease, Neurodegenerative Disease Management, vol.3, issue.3, 2013. ,
DOI : 10.2217/nmt.13.18
Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature, J. Child Neurol, vol.21, pp.223-229, 2006. ,
Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume, American Journal of Medical Genetics Part A, vol.67, issue.4, pp.815-818, 2011. ,
DOI : 10.1002/ajmg.a.33911
Late onset of Huntington's disease., Journal of Neurology, Neurosurgery & Psychiatry, vol.48, issue.6, pp.530-534, 1985. ,
DOI : 10.1136/jnnp.48.6.530
Molecular analysis of late onset Huntington's disease., Journal of Medical Genetics, vol.30, issue.12, pp.991-995, 1993. ,
DOI : 10.1136/jmg.30.12.991
Late-onset Huntington's Disease: A Clinical and Molecular Study, Age and Ageing, vol.23, issue.6, pp.445-448, 1994. ,
DOI : 10.1093/ageing/23.6.445
Late onset Huntington Disease: Clinical and genetic characteristics of 34 cases, Journal of the Neurological Sciences, vol.276, issue.1-2, pp.159-162, 2009. ,
DOI : 10.1016/j.jns.2008.09.029
Late-onset Huntington's disease: Diagnostic and prognostic considerations, Parkinsonism & Related Disorders, vol.20, issue.7, pp.726-730, 2014. ,
DOI : 10.1016/j.parkreldis.2014.03.017
A polymorphic DNA marker genetically linked to Huntington's disease, Nature, vol.76, issue.5940, pp.234-238, 1983. ,
DOI : 10.1016/0378-1119(79)90051-9
Genetics and Neuropathology of Huntington's Disease, Int. Rev. Neurobiol, vol.98, pp.325-372, 2011. ,
DOI : 10.1016/B978-0-12-381328-2.00014-6
CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease, Journal of Medical Genetics, vol.84, issue.10, pp.696-703, 2013. ,
DOI : 10.1136/jmedgenet-2013-101796
Huntington's disease as caused by 34 CAG repeats, Movement Disorders, vol.44, issue.6, pp.879-881, 2008. ,
DOI : 10.1002/mds.21958
Autopsy-proven Huntington's disease with 29 trinucleotide repeats, Movement Disorders, vol.76, issue.1, pp.127-130, 2007. ,
DOI : 10.1002/mds.21195
The association of CAG repeat length with clinical progression in Huntington disease, Neurology, vol.66, issue.7, pp.1016-1020, 2006. ,
DOI : 10.1212/01.wnl.0000204230.16619.d9
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease, American Journal of Medical Genetics Part A, vol.2, issue.3, pp.279-282, 2003. ,
DOI : 10.1002/ajmg.a.20190
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion, Neurology, vol.78, issue.10, pp.690-695, 2012. ,
DOI : 10.1212/WNL.0b013e318249f683
The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease, Movement Disorders, vol.27, issue.1, pp.125-129, 2011. ,
DOI : 10.1002/mds.23436
A Genome Scan for Modifiers of Age at Onset in Huntington Disease: The HD MAPS Study, The American Journal of Human Genetics, vol.73, issue.3, pp.682-687, 2003. ,
DOI : 10.1086/378133
Evidence for the GluR6 gene associated with younger onset age of Huntington's disease, Neurology, vol.53, issue.6, pp.1330-1332, 1999. ,
DOI : 10.1212/WNL.53.6.1330
Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease, Proceedings of the National Academy of Sciences, vol.94, issue.8, pp.3872-3876, 1997. ,
DOI : 10.1073/pnas.94.8.3872
Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease, Human Molecular Genetics, vol.17, issue.8, pp.1137-1146, 2008. ,
DOI : 10.1093/hmg/ddn003
Juvenile Huntington's disease: Does a dosage-effect pathogenic mechanism differ from the classical adult disease?, Mechanisms of Ageing and Development, vol.127, issue.2, pp.208-212, 2006. ,
DOI : 10.1016/j.mad.2005.09.012
Pathogenesis of polyglutamine disorders: aggregation revisited, Human Molecular Genetics, vol.12, issue.suppl 2, pp.173-186, 2003. ,
DOI : 10.1093/hmg/ddg295
Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology, J. Neurosci. Off. J. Soc. Neurosci, vol.19, pp.2522-2534, 1999. ,
Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates, Nature Genetics, vol.51, issue.2, pp.150-154, 1998. ,
DOI : 10.1016/0014-5793(94)00415-3
Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions, Cell, vol.95, issue.1, pp.55-66, 1998. ,
DOI : 10.1016/S0092-8674(00)81782-1
The hunt for huntingtin function: interaction partners tell many different stories, Trends in Biochemical Sciences, vol.28, issue.8, pp.425-433, 2003. ,
DOI : 10.1016/S0968-0004(03)00168-3
Huntingtin???protein interactions and the pathogenesis of Huntington's disease, Trends in Genetics, vol.20, issue.3, pp.146-154, 2004. ,
DOI : 10.1016/j.tig.2004.01.008
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease, Science, vol.293, issue.5529, pp.493-498, 2001. ,
DOI : 10.1126/science.1059581
Neuropathological Classification of Huntington??s Disease, Journal of Neuropathology and Experimental Neurology, vol.44, issue.6, pp.559-577, 1985. ,
DOI : 10.1097/00005072-198511000-00003
Huntington disease models and human neuropathology: similarities and differences, Acta Neuropathologica, vol.31, issue.1, pp.55-69, 2008. ,
DOI : 10.1007/s00401-007-0306-6
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847401
Bicaudate diameter?the most specific and simple CT parameter in the diagnosis of Huntington's disease, Neuroradiology, vol.28, issue.1, pp.25-28, 1984. ,
DOI : 10.1007/BF00328198
fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease, AJNR Am. J. Neuroradiol, vol.25, pp.1715-1721, 2004. ,
Striatal volume loss in HD as measured by MRI and the influence of CAG repeat, Neurology, vol.57, issue.6, pp.1025-1028, 2001. ,
DOI : 10.1212/WNL.57.6.1025
Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease, Journal of Neuropathology & Experimental Neurology, vol.47, issue.5, pp.516-525, 1988. ,
DOI : 10.1097/00005072-198809000-00003
PET imaging shows loss of striatal PDE10A in patients with Huntington disease, Neurology, vol.82, issue.3, pp.279-281, 2014. ,
DOI : 10.1212/WNL.0000000000000037
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial, Neurology, vol.66, pp.366-372, 2006. ,
Treatment of Huntington Disease, Current Treatment Options in Neurology, vol.56, issue.2, pp.424-438, 2013. ,
DOI : 10.1007/s11940-013-0219-8
Acetyl Cholinesterase inhibitors in cognitive impairment in Huntington???s disease: A brief review, World Journal of Psychiatry, vol.3, issue.3, pp.62-64, 2013. ,
DOI : 10.5498/wjp.v3.i3.62
Therapeutic advances in Huntington's Disease, Movement Disorders, vol.69, issue.11, 2015. ,
DOI : 10.1002/mds.26331
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease, Neurology, vol.57, pp.397-404, 2001. ,
Riluzole in Huntington's disease: a 3-year, randomized controlled study, Annals of Neurology, vol.57, issue.3, pp.262-272, 2007. ,
DOI : 10.1002/ana.21181
Thalamotomy and pallidotomy for treatment of choreic movements, Acta Neurochirurgica, vol.74, issue.3-4, pp.417-422, 1952. ,
DOI : 10.1007/BF01405833
Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study, Journal of Neurosurgery, vol.121, issue.1, pp.114-122, 2014. ,
DOI : 10.3171/2014.2.JNS131722
Chapter 17 Striatal tissue transplantation in non-human primates, Prog. Brain Res, vol.127, pp.381-404, 2000. ,
DOI : 10.1016/S0079-6123(00)27018-0
Striatal grafts in rats with unilateral neostriatal lesions???III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching, Neuroscience, vol.24, issue.3, pp.813-820, 1988. ,
DOI : 10.1016/0306-4522(88)90069-3
Motor and cognitive improvements in patients with Huntington's disease after neural transplantation, The Lancet, vol.356, issue.9246, pp.1975-1979, 2000. ,
DOI : 10.1016/S0140-6736(00)03310-9
Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study, The Lancet Neurology, vol.5, issue.4, pp.303-309, 2006. ,
DOI : 10.1016/S1474-4422(06)70381-7
Fetal striatal grafting slows motor and cognitive decline of Huntington's disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.47, issue.9, pp.974-981, 2014. ,
DOI : 10.1136/jnnp-2013-306533
Mutant huntingtin is present in neuronal grafts in huntington disease patients, Annals of Neurology, vol.68, issue.1, pp.31-42, 2014. ,
DOI : 10.1002/ana.24174
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.12, pp.1409-1412, 2011. ,
DOI : 10.1136/jnnp.2010.209668
Falls and gait disturbances in Huntington's disease, Movement Disorders, vol.248, issue.7, pp.970-976, 2008. ,
DOI : 10.1002/mds.22003
Alzheimer-type lesions in Huntington's disease, Journal of Neural Transmission, vol.105, issue.8-9, pp.787-799, 1996. ,
DOI : 10.1007/s007020050095
The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects, J. Huntingt. Dis, vol.3, pp.209-217, 2014. ,
Chorea Huntington mit sp??ter Manifestation als Differenzialdiagnose der Alzheimer-Krankheit, Der Nervenarzt, vol.73, issue.9, pp.870-873, 2002. ,
DOI : 10.1007/s00115-002-1361-9